Replies to post #268910 on Avid Bioservices Inc (CDMO)

[sulaco]

Adjunctive chemo or adjunctive hormonal


therapy, either way, you have no evidence for enhancing your solo I/O 1.0 downstream inhibitors with adjunctive approaches. There's just no evidence.

Those studies may be pending, but so are the Bavi studies with NCCN, MSK and AZN. And they're much closer to starting.

We all need to take a step back once a week and consider our options. If we believe enhancement of I/O 1.0 downstream inhibitors with adjunctive agents is the way forward, it would be best to sell PPHM and move on.